Late Breaking Abstract - Azithromycin for acute COPD exacerbations requiring hospitalization – the BACE trial results

K. Vermeersch (Leuven, Belgium), M. Gabrovska (Brussel, Belgium), J. Aumann (Hasselt, Belgium), I. Demedts (Roeselare, Belgium), J. Corhay (Luik, Belgium), E. Marchand (Yvoir, Belgium), H. Slabbynck (Antwerpen, Belgium), C. Haenebalcke (Brugge, Belgium), M. Haerens (Kortrijk, Belgium), S. Hanon (Brussel, Belgium), P. Nguyen (Aalst, Belgium), R. Peché (Charleroi, Belgium), A. Fremault (Charleroi, Belgium), T. Lauwerier (Bonheiden, Belgium), B. Vandenberk (Leuven, Belgium), S. Everaerts (Leuven, Belgium), V. Ninane (Brussel, Belgium), G. Verleden (Leuven, Belgium), T. Troosters (Leuven, Belgium), K. Bogaerts (Leuven, Belgium), G. Brusselle (Gent, Belgium), W. Janssens (Leuven, Belgium)

Source: International Congress 2018 – Clinical trials in COPD: new results
Session: Clinical trials in COPD: new results
Session type: Oral Presentation
Number: 1654
Disease area: Airway diseases

Congress or journal article abstractSlide presentationWebcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Vermeersch (Leuven, Belgium), M. Gabrovska (Brussel, Belgium), J. Aumann (Hasselt, Belgium), I. Demedts (Roeselare, Belgium), J. Corhay (Luik, Belgium), E. Marchand (Yvoir, Belgium), H. Slabbynck (Antwerpen, Belgium), C. Haenebalcke (Brugge, Belgium), M. Haerens (Kortrijk, Belgium), S. Hanon (Brussel, Belgium), P. Nguyen (Aalst, Belgium), R. Peché (Charleroi, Belgium), A. Fremault (Charleroi, Belgium), T. Lauwerier (Bonheiden, Belgium), B. Vandenberk (Leuven, Belgium), S. Everaerts (Leuven, Belgium), V. Ninane (Brussel, Belgium), G. Verleden (Leuven, Belgium), T. Troosters (Leuven, Belgium), K. Bogaerts (Leuven, Belgium), G. Brusselle (Gent, Belgium), W. Janssens (Leuven, Belgium). Late Breaking Abstract - Azithromycin for acute COPD exacerbations requiring hospitalization – the BACE trial results. 1654

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Early discharge COPD experience: Reduction of severe exacerbations requiring hospitalisation
Source: Annual Congress 2012 - The latest insights in chronic care
Year: 2012


Time-to-treatment failure in the Belgian randomized controlled trial with azithromycin for acute COPD exacerbations requiring hospitalization
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016


Late Breaking Abstract - Silent exacerbations: underreporting of COPD exacerbations in Poland
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020


Pulmonary rehabilitation following hospitalisation for acute exacerbation of COPD: Fact or fiction?
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013


Procalcitonin-guided antibiotic therapy in acute exacerbations of COPD (AECOPD): a randomised trial - The ProCOLD Study
Source: Eur Respir J 2005; 26: Suppl. 49, 464s
Year: 2005

Late Breaking Abstract - Mepolizumab reduces exacerbations in eosinophilic COPD
Source: International Congress 2017 – Late-breaking studies in asthma and COPD
Year: 2017



Effect of telehealthcare on exacerbations and hospital admissions in COPD: A randomised controlled trial
Source: International Congress 2015 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2015


Hospitalization cost analysis due to acute COPD exacerbations
Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system
Year: 2016


Does having previous sputum results improve rationalisation of antimicrobial prescribing during acute exacerbations of COPD?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015

COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016


Erdosteine oral treatment of hospitalised COPD exacerbation prolongs time to first re-exacerbation
Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases
Year: 2014


Can antibiotics prevent acute COPD exacerbation? A systematic review and meta-analysis
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013

Late Breaking Abstract - Trial of c-reactive protein point of care testing (CRP-POCT) for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease (COPD) in primary care
Source: International Congress 2018 – Primary care management of respiratory conditions
Year: 2018



Gait speed is a predictor of readmission following hospitalisation for acute exacerbations of COPD
Source: International Congress 2014 – Best abstracts in physical activity and exercise testing
Year: 2014

Late Breaking Abstract - Corticosteroids reduce mortality and prevent ICU admission in Covid-19 pneumonia – results from a rapid clinical review of 191 patients
Source: Virtual Congress 2020 – COVID-19 clinical studies
Year: 2020


Outpatient care for reducing readmissions of patients hospitalized for exacerbation of COPD
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015


Characterization of readmissions in patients hospitalized with COPD exacerbation
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016